CLINICAL AND EXPERIMENTAL IMMUNOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=521815, encodeId=25cc5218155e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿三周收到身高意见，要求小修。三个审稿人，第一个说我的缩写大小写都不统一，花了半夜批评我的态度，但是没提任何意见；第二个说我这是个很有意思的工作，夸了夸，说有一个流式图不合适，让我改改。第三个是最懂我工作的，说让我改一改讨论，深入讨论下我发现的问题，然后还谈了他的看法，并且附了一篇参考文献说让我好好读读，我估计是他写的吧。我一直拖着没改，两周后杂志社给我发邮件说让我注意修改的期限，我改了上传后次日接收。感觉特别快，编辑很友好。这个杂志手版面费，160美元，也可以交英镑，更加便宜，反正合成人民币的话是1060元，不贵，性价比超高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=675144120, createdName=recalling, createdTime=Thu Apr 28 15:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586988, encodeId=26ff586988e2, content=审稿速度:1.0 经验分享：已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/9f4f2edd3b3428529861a64b1cc3a29a.jpg, createdBy=0de52441655, createdName=负70℃思考, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576932, encodeId=1f0b5e6932a8, content=28天后拒稿，没有送外审，就说不适合这个杂志……顺便说一下，投稿时和拒稿时会给所有作者抄送邮件……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe25195837, createdName=14727f11m22(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160067, encodeId=b959216006ee7, content=6月13日投稿，到现在还是在under review，发了两次催稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Sep 27 16:38:02 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=550037, encodeId=864955003ed3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：初审约1个月，两个审稿人各给了10条左右大大小小的意见，给3个月补实验修改，10天后通知可以接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29d2220990, createdName=wangweiwei365_64903392, createdTime=Fri Dec 15 13:12:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099521, encodeId=4b8b209952167, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：gsf, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Thu Nov 10 00:11:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211954, encodeId=116412119544a, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：免疫;消化内科 经验分享：3月14号投稿，3月8号催稿后第二天回信，3月14号两个审稿人意见返回，16号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c728121082, createdName=ms1000000245842116, createdTime=Sun Apr 17 17:55:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2016-04-28 recalling

审稿速度:1.0 | 投稿命中率:25.0
经验分享：投稿三周收到身高意见，要求小修。三个审稿人，第一个说我的缩写大小写都不统一，花了半夜批评我的态度，但是没提任何意见；第二个说我这是个很有意思的工作，夸了夸，说有一个流式图不合适，让我改改。第三个是最懂我工作的，说让我改一改讨论，深入讨论下我发现的问题，然后还谈了他的看法，并且附了一篇参考文献说让我好好读读，我估计是他写的吧。我一直拖着没改，两周后杂志社给我发邮件说让我注意修改的期限，我改了上传后次日接收。感觉特别快，编辑很友好。这个杂志手版面费，160美元，也可以交英镑，更加便宜，反正合成人民币的话是1060元，不贵，性价比超高

319 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=521815, encodeId=25cc5218155e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿三周收到身高意见，要求小修。三个审稿人，第一个说我的缩写大小写都不统一，花了半夜批评我的态度，但是没提任何意见；第二个说我这是个很有意思的工作，夸了夸，说有一个流式图不合适，让我改改。第三个是最懂我工作的，说让我改一改讨论，深入讨论下我发现的问题，然后还谈了他的看法，并且附了一篇参考文献说让我好好读读，我估计是他写的吧。我一直拖着没改，两周后杂志社给我发邮件说让我注意修改的期限，我改了上传后次日接收。感觉特别快，编辑很友好。这个杂志手版面费，160美元，也可以交英镑，更加便宜，反正合成人民币的话是1060元，不贵，性价比超高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=675144120, createdName=recalling, createdTime=Thu Apr 28 15:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586988, encodeId=26ff586988e2, content=审稿速度:1.0 经验分享：已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/9f4f2edd3b3428529861a64b1cc3a29a.jpg, createdBy=0de52441655, createdName=负70℃思考, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576932, encodeId=1f0b5e6932a8, content=28天后拒稿，没有送外审，就说不适合这个杂志……顺便说一下，投稿时和拒稿时会给所有作者抄送邮件……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe25195837, createdName=14727f11m22(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160067, encodeId=b959216006ee7, content=6月13日投稿，到现在还是在under review，发了两次催稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Sep 27 16:38:02 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=550037, encodeId=864955003ed3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：初审约1个月，两个审稿人各给了10条左右大大小小的意见，给3个月补实验修改，10天后通知可以接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29d2220990, createdName=wangweiwei365_64903392, createdTime=Fri Dec 15 13:12:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099521, encodeId=4b8b209952167, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：gsf, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Thu Nov 10 00:11:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211954, encodeId=116412119544a, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：免疫;消化内科 经验分享：3月14号投稿，3月8号催稿后第二天回信，3月14号两个审稿人意见返回，16号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c728121082, createdName=ms1000000245842116, createdTime=Sun Apr 17 17:55:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-03-20 负70℃思考

审稿速度:1.0
经验分享：已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！

157 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=521815, encodeId=25cc5218155e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿三周收到身高意见，要求小修。三个审稿人，第一个说我的缩写大小写都不统一，花了半夜批评我的态度，但是没提任何意见；第二个说我这是个很有意思的工作，夸了夸，说有一个流式图不合适，让我改改。第三个是最懂我工作的，说让我改一改讨论，深入讨论下我发现的问题，然后还谈了他的看法，并且附了一篇参考文献说让我好好读读，我估计是他写的吧。我一直拖着没改，两周后杂志社给我发邮件说让我注意修改的期限，我改了上传后次日接收。感觉特别快，编辑很友好。这个杂志手版面费，160美元，也可以交英镑，更加便宜，反正合成人民币的话是1060元，不贵，性价比超高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=675144120, createdName=recalling, createdTime=Thu Apr 28 15:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586988, encodeId=26ff586988e2, content=审稿速度:1.0 经验分享：已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/9f4f2edd3b3428529861a64b1cc3a29a.jpg, createdBy=0de52441655, createdName=负70℃思考, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576932, encodeId=1f0b5e6932a8, content=28天后拒稿，没有送外审，就说不适合这个杂志……顺便说一下，投稿时和拒稿时会给所有作者抄送邮件……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe25195837, createdName=14727f11m22(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160067, encodeId=b959216006ee7, content=6月13日投稿，到现在还是在under review，发了两次催稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Sep 27 16:38:02 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=550037, encodeId=864955003ed3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：初审约1个月，两个审稿人各给了10条左右大大小小的意见，给3个月补实验修改，10天后通知可以接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29d2220990, createdName=wangweiwei365_64903392, createdTime=Fri Dec 15 13:12:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099521, encodeId=4b8b209952167, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：gsf, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Thu Nov 10 00:11:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211954, encodeId=116412119544a, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：免疫;消化内科 经验分享：3月14号投稿，3月8号催稿后第二天回信，3月14号两个审稿人意见返回，16号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c728121082, createdName=ms1000000245842116, createdTime=Sun Apr 17 17:55:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2019-09-25 14727f11m22(暂无昵称)

28天后拒稿，没有送外审，就说不适合这个杂志……顺便说一下，投稿时和拒稿时会给所有作者抄送邮件……

174 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=521815, encodeId=25cc5218155e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿三周收到身高意见，要求小修。三个审稿人，第一个说我的缩写大小写都不统一，花了半夜批评我的态度，但是没提任何意见；第二个说我这是个很有意思的工作，夸了夸，说有一个流式图不合适，让我改改。第三个是最懂我工作的，说让我改一改讨论，深入讨论下我发现的问题，然后还谈了他的看法，并且附了一篇参考文献说让我好好读读，我估计是他写的吧。我一直拖着没改，两周后杂志社给我发邮件说让我注意修改的期限，我改了上传后次日接收。感觉特别快，编辑很友好。这个杂志手版面费，160美元，也可以交英镑，更加便宜，反正合成人民币的话是1060元，不贵，性价比超高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=675144120, createdName=recalling, createdTime=Thu Apr 28 15:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586988, encodeId=26ff586988e2, content=审稿速度:1.0 经验分享：已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/9f4f2edd3b3428529861a64b1cc3a29a.jpg, createdBy=0de52441655, createdName=负70℃思考, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576932, encodeId=1f0b5e6932a8, content=28天后拒稿，没有送外审，就说不适合这个杂志……顺便说一下，投稿时和拒稿时会给所有作者抄送邮件……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe25195837, createdName=14727f11m22(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160067, encodeId=b959216006ee7, content=6月13日投稿，到现在还是在under review，发了两次催稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Sep 27 16:38:02 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=550037, encodeId=864955003ed3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：初审约1个月，两个审稿人各给了10条左右大大小小的意见，给3个月补实验修改，10天后通知可以接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29d2220990, createdName=wangweiwei365_64903392, createdTime=Fri Dec 15 13:12:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099521, encodeId=4b8b209952167, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：gsf, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Thu Nov 10 00:11:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211954, encodeId=116412119544a, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：免疫;消化内科 经验分享：3月14号投稿，3月8号催稿后第二天回信，3月14号两个审稿人意见返回，16号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c728121082, createdName=ms1000000245842116, createdTime=Sun Apr 17 17:55:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-09-27 758880040 来自江苏省

6月13日投稿，到现在还是在under review，发了两次催稿信

31 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=521815, encodeId=25cc5218155e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿三周收到身高意见，要求小修。三个审稿人，第一个说我的缩写大小写都不统一，花了半夜批评我的态度，但是没提任何意见；第二个说我这是个很有意思的工作，夸了夸，说有一个流式图不合适，让我改改。第三个是最懂我工作的，说让我改一改讨论，深入讨论下我发现的问题，然后还谈了他的看法，并且附了一篇参考文献说让我好好读读，我估计是他写的吧。我一直拖着没改，两周后杂志社给我发邮件说让我注意修改的期限，我改了上传后次日接收。感觉特别快，编辑很友好。这个杂志手版面费，160美元，也可以交英镑，更加便宜，反正合成人民币的话是1060元，不贵，性价比超高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=675144120, createdName=recalling, createdTime=Thu Apr 28 15:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586988, encodeId=26ff586988e2, content=审稿速度:1.0 经验分享：已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/9f4f2edd3b3428529861a64b1cc3a29a.jpg, createdBy=0de52441655, createdName=负70℃思考, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576932, encodeId=1f0b5e6932a8, content=28天后拒稿，没有送外审，就说不适合这个杂志……顺便说一下，投稿时和拒稿时会给所有作者抄送邮件……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe25195837, createdName=14727f11m22(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160067, encodeId=b959216006ee7, content=6月13日投稿，到现在还是在under review，发了两次催稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Sep 27 16:38:02 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=550037, encodeId=864955003ed3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：初审约1个月，两个审稿人各给了10条左右大大小小的意见，给3个月补实验修改，10天后通知可以接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29d2220990, createdName=wangweiwei365_64903392, createdTime=Fri Dec 15 13:12:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099521, encodeId=4b8b209952167, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：gsf, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Thu Nov 10 00:11:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211954, encodeId=116412119544a, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：免疫;消化内科 经验分享：3月14号投稿，3月8号催稿后第二天回信，3月14号两个审稿人意见返回，16号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c728121082, createdName=ms1000000245842116, createdTime=Sun Apr 17 17:55:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2017-12-15 wangweiwei365_64903392

审稿速度:1.0 | 投稿命中率:50.0
经验分享：初审约1个月，两个审稿人各给了10条左右大大小小的意见，给3个月补实验修改，10天后通知可以接收。

353 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=521815, encodeId=25cc5218155e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿三周收到身高意见，要求小修。三个审稿人，第一个说我的缩写大小写都不统一，花了半夜批评我的态度，但是没提任何意见；第二个说我这是个很有意思的工作，夸了夸，说有一个流式图不合适，让我改改。第三个是最懂我工作的，说让我改一改讨论，深入讨论下我发现的问题，然后还谈了他的看法，并且附了一篇参考文献说让我好好读读，我估计是他写的吧。我一直拖着没改，两周后杂志社给我发邮件说让我注意修改的期限，我改了上传后次日接收。感觉特别快，编辑很友好。这个杂志手版面费，160美元，也可以交英镑，更加便宜，反正合成人民币的话是1060元，不贵，性价比超高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=675144120, createdName=recalling, createdTime=Thu Apr 28 15:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586988, encodeId=26ff586988e2, content=审稿速度:1.0 经验分享：已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/9f4f2edd3b3428529861a64b1cc3a29a.jpg, createdBy=0de52441655, createdName=负70℃思考, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576932, encodeId=1f0b5e6932a8, content=28天后拒稿，没有送外审，就说不适合这个杂志……顺便说一下，投稿时和拒稿时会给所有作者抄送邮件……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe25195837, createdName=14727f11m22(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160067, encodeId=b959216006ee7, content=6月13日投稿，到现在还是在under review，发了两次催稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Sep 27 16:38:02 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=550037, encodeId=864955003ed3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：初审约1个月，两个审稿人各给了10条左右大大小小的意见，给3个月补实验修改，10天后通知可以接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29d2220990, createdName=wangweiwei365_64903392, createdTime=Fri Dec 15 13:12:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099521, encodeId=4b8b209952167, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：gsf, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Thu Nov 10 00:11:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211954, encodeId=116412119544a, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：免疫;消化内科 经验分享：3月14号投稿，3月8号催稿后第二天回信，3月14号两个审稿人意见返回，16号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c728121082, createdName=ms1000000245842116, createdTime=Sun Apr 17 17:55:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-11-10 ms3000000590360295

审稿速度:2.0 | 投稿命中率:75.0
经验分享：gsf

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=521815, encodeId=25cc5218155e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿三周收到身高意见，要求小修。三个审稿人，第一个说我的缩写大小写都不统一，花了半夜批评我的态度，但是没提任何意见；第二个说我这是个很有意思的工作，夸了夸，说有一个流式图不合适，让我改改。第三个是最懂我工作的，说让我改一改讨论，深入讨论下我发现的问题，然后还谈了他的看法，并且附了一篇参考文献说让我好好读读，我估计是他写的吧。我一直拖着没改，两周后杂志社给我发邮件说让我注意修改的期限，我改了上传后次日接收。感觉特别快，编辑很友好。这个杂志手版面费，160美元，也可以交英镑，更加便宜，反正合成人民币的话是1060元，不贵，性价比超高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=675144120, createdName=recalling, createdTime=Thu Apr 28 15:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586988, encodeId=26ff586988e2, content=审稿速度:1.0 经验分享：已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/9f4f2edd3b3428529861a64b1cc3a29a.jpg, createdBy=0de52441655, createdName=负70℃思考, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576932, encodeId=1f0b5e6932a8, content=28天后拒稿，没有送外审，就说不适合这个杂志……顺便说一下，投稿时和拒稿时会给所有作者抄送邮件……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe25195837, createdName=14727f11m22(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160067, encodeId=b959216006ee7, content=6月13日投稿，到现在还是在under review，发了两次催稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Sep 27 16:38:02 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=550037, encodeId=864955003ed3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：初审约1个月，两个审稿人各给了10条左右大大小小的意见，给3个月补实验修改，10天后通知可以接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29d2220990, createdName=wangweiwei365_64903392, createdTime=Fri Dec 15 13:12:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099521, encodeId=4b8b209952167, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：gsf, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Thu Nov 10 00:11:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211954, encodeId=116412119544a, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：免疫;消化内科 经验分享：3月14号投稿，3月8号催稿后第二天回信，3月14号两个审稿人意见返回，16号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c728121082, createdName=ms1000000245842116, createdTime=Sun Apr 17 17:55:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-04-17 ms1000000245842116

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：免疫;消化内科
经验分享：3月14号投稿，3月8号催稿后第二天回信，3月14号两个审稿人意见返回，16号接收。

49 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=521815, encodeId=25cc5218155e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿三周收到身高意见，要求小修。三个审稿人，第一个说我的缩写大小写都不统一，花了半夜批评我的态度，但是没提任何意见；第二个说我这是个很有意思的工作，夸了夸，说有一个流式图不合适，让我改改。第三个是最懂我工作的，说让我改一改讨论，深入讨论下我发现的问题，然后还谈了他的看法，并且附了一篇参考文献说让我好好读读，我估计是他写的吧。我一直拖着没改，两周后杂志社给我发邮件说让我注意修改的期限，我改了上传后次日接收。感觉特别快，编辑很友好。这个杂志手版面费，160美元，也可以交英镑，更加便宜，反正合成人民币的话是1060元，不贵，性价比超高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=675144120, createdName=recalling, createdTime=Thu Apr 28 15:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586988, encodeId=26ff586988e2, content=审稿速度:1.0 经验分享：已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/9f4f2edd3b3428529861a64b1cc3a29a.jpg, createdBy=0de52441655, createdName=负70℃思考, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576932, encodeId=1f0b5e6932a8, content=28天后拒稿，没有送外审，就说不适合这个杂志……顺便说一下，投稿时和拒稿时会给所有作者抄送邮件……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe25195837, createdName=14727f11m22(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160067, encodeId=b959216006ee7, content=6月13日投稿，到现在还是在under review，发了两次催稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Sep 27 16:38:02 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=550037, encodeId=864955003ed3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：初审约1个月，两个审稿人各给了10条左右大大小小的意见，给3个月补实验修改，10天后通知可以接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29d2220990, createdName=wangweiwei365_64903392, createdTime=Fri Dec 15 13:12:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099521, encodeId=4b8b209952167, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：gsf, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Thu Nov 10 00:11:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211954, encodeId=116412119544a, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：免疫;消化内科 经验分享：3月14号投稿，3月8号催稿后第二天回信，3月14号两个审稿人意见返回，16号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c728121082, createdName=ms1000000245842116, createdTime=Sun Apr 17 17:55:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-11-20 ms1000000807569714

刚投稿就是 under review嘛，直接到ADM那里?

114 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=521815, encodeId=25cc5218155e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿三周收到身高意见，要求小修。三个审稿人，第一个说我的缩写大小写都不统一，花了半夜批评我的态度，但是没提任何意见；第二个说我这是个很有意思的工作，夸了夸，说有一个流式图不合适，让我改改。第三个是最懂我工作的，说让我改一改讨论，深入讨论下我发现的问题，然后还谈了他的看法，并且附了一篇参考文献说让我好好读读，我估计是他写的吧。我一直拖着没改，两周后杂志社给我发邮件说让我注意修改的期限，我改了上传后次日接收。感觉特别快，编辑很友好。这个杂志手版面费，160美元，也可以交英镑，更加便宜，反正合成人民币的话是1060元，不贵，性价比超高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=675144120, createdName=recalling, createdTime=Thu Apr 28 15:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586988, encodeId=26ff586988e2, content=审稿速度:1.0 经验分享：已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/9f4f2edd3b3428529861a64b1cc3a29a.jpg, createdBy=0de52441655, createdName=负70℃思考, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576932, encodeId=1f0b5e6932a8, content=28天后拒稿，没有送外审，就说不适合这个杂志……顺便说一下，投稿时和拒稿时会给所有作者抄送邮件……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe25195837, createdName=14727f11m22(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160067, encodeId=b959216006ee7, content=6月13日投稿，到现在还是在under review，发了两次催稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Sep 27 16:38:02 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=550037, encodeId=864955003ed3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：初审约1个月，两个审稿人各给了10条左右大大小小的意见，给3个月补实验修改，10天后通知可以接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29d2220990, createdName=wangweiwei365_64903392, createdTime=Fri Dec 15 13:12:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099521, encodeId=4b8b209952167, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：gsf, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Thu Nov 10 00:11:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211954, encodeId=116412119544a, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：免疫;消化内科 经验分享：3月14号投稿，3月8号催稿后第二天回信，3月14号两个审稿人意见返回，16号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c728121082, createdName=ms1000000245842116, createdTime=Sun Apr 17 17:55:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-29 MS68862005

所有作者在文章接收之后都会接收到邮件吗？

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=521815, encodeId=25cc5218155e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿三周收到身高意见，要求小修。三个审稿人，第一个说我的缩写大小写都不统一，花了半夜批评我的态度，但是没提任何意见；第二个说我这是个很有意思的工作，夸了夸，说有一个流式图不合适，让我改改。第三个是最懂我工作的，说让我改一改讨论，深入讨论下我发现的问题，然后还谈了他的看法，并且附了一篇参考文献说让我好好读读，我估计是他写的吧。我一直拖着没改，两周后杂志社给我发邮件说让我注意修改的期限，我改了上传后次日接收。感觉特别快，编辑很友好。这个杂志手版面费，160美元，也可以交英镑，更加便宜，反正合成人民币的话是1060元，不贵，性价比超高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=675144120, createdName=recalling, createdTime=Thu Apr 28 15:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586988, encodeId=26ff586988e2, content=审稿速度:1.0 经验分享：已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/9f4f2edd3b3428529861a64b1cc3a29a.jpg, createdBy=0de52441655, createdName=负70℃思考, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576932, encodeId=1f0b5e6932a8, content=28天后拒稿，没有送外审，就说不适合这个杂志……顺便说一下，投稿时和拒稿时会给所有作者抄送邮件……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe25195837, createdName=14727f11m22(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160067, encodeId=b959216006ee7, content=6月13日投稿，到现在还是在under review，发了两次催稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Sep 27 16:38:02 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=550037, encodeId=864955003ed3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：初审约1个月，两个审稿人各给了10条左右大大小小的意见，给3个月补实验修改，10天后通知可以接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29d2220990, createdName=wangweiwei365_64903392, createdTime=Fri Dec 15 13:12:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099521, encodeId=4b8b209952167, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：gsf, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Thu Nov 10 00:11:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211954, encodeId=116412119544a, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：免疫;消化内科 经验分享：3月14号投稿，3月8号催稿后第二天回信，3月14号两个审稿人意见返回，16号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c728121082, createdName=ms1000000245842116, createdTime=Sun Apr 17 17:55:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 乌云背后的幸福线

同一杂志社不同期刊如何转投（transfer）？

0 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务